ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 110 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,810,061 | -11.7% | 8,280,818 | 0.0% | 3.38% | -18.8% |
| Q2 2023 | $19,045,881 | -15.8% | 8,280,818 | +10.9% | 4.16% | -79.9% |
| Q1 2023 | $22,618,114 | +29.4% | 7,464,724 | -0.5% | 20.76% | +25.0% |
| Q4 2022 | $17,484,770 | +61.9% | 7,504,193 | +32.7% | 16.61% | +68.4% |
| Q3 2022 | $10,799,000 | +13.8% | 5,653,917 | +61.5% | 9.86% | -20.2% |
| Q2 2022 | $9,490,000 | +44.8% | 3,501,876 | +59.2% | 12.35% | +125.0% |
| Q1 2022 | $6,553,000 | +104.1% | 2,199,069 | +166.4% | 5.49% | +122.7% |
| Q4 2021 | $3,211,000 | – | 825,569 | – | 2.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |